Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Current Urology Reports
|
April 29, 2010
Emerging therapies in castrate-resistant prostate cancer
Luai Zarour, Joshi Alumkal
Epigenetics
|
February 18, 2010
Epigenetic regulation of androgen receptor signaling in prostate cancer
Lina Gao, Joshi Alumkal
Cancer Biology & Therapy
|
March 19, 2008
hADA2a and hADA3: new players in beta-catenin signaling
Katy Van Hook, Joshi Alumkal, Charles D Lopez
Proceedings of the National Academy of Sciences of the United States of America
|
October 7, 2009
Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6
Angela Gibbs, Jacob Schwartzman, Vivianne Deng, et al.
Pituitary
|
July 30, 2009
Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes
Troy Dillard, Chris G Yedinak, Joshi Alumkal, et al.
Anti-Cancer Drugs
|
December 18, 2009
A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy
Tomasz M Beer, Charles Ryan, Joshi Alumkal, et al.
Discovery Medicine
|
April 2, 2015
CHFR methylation strongly correlates with methylation of DNA damage repair and apoptotic pathway genes in non-small cell lung cancer
Mingzhou Guo, Joshi Alumkal, Tatiana Drachova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 18, 2018
Reply to A. Dalla Volta et al
Rahul Aggarwal, Jiaoti Huang, Joshi Alumkal, et al.
Plos One
|
May 25, 2013
Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation
Lina Gao, Jacob Schwartzman, Angela Gibbs, et al.
Scientific Reports
|
December 11, 2020
Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease
Rebecca Smith, Moqing Liu, Tiera Liby, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Current Urology Reports
|
April 29, 2010
Emerging therapies in castrate-resistant prostate cancer
Luai Zarour, Joshi Alumkal
Epigenetics
|
February 18, 2010
Epigenetic regulation of androgen receptor signaling in prostate cancer
Lina Gao, Joshi Alumkal
Cancer Biology & Therapy
|
March 19, 2008
hADA2a and hADA3: new players in beta-catenin signaling
Katy Van Hook, Joshi Alumkal, Charles D Lopez
Proceedings of the National Academy of Sciences of the United States of America
|
October 7, 2009
Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6
Angela Gibbs, Jacob Schwartzman, Vivianne Deng, et al.
Pituitary
|
July 30, 2009
Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes
Troy Dillard, Chris G Yedinak, Joshi Alumkal, et al.
Anti-Cancer Drugs
|
December 18, 2009
A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate cancer after docetaxel chemotherapy
Tomasz M Beer, Charles Ryan, Joshi Alumkal, et al.
Discovery Medicine
|
April 2, 2015
CHFR methylation strongly correlates with methylation of DNA damage repair and apoptotic pathway genes in non-small cell lung cancer
Mingzhou Guo, Joshi Alumkal, Tatiana Drachova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 18, 2018
Reply to A. Dalla Volta et al
Rahul Aggarwal, Jiaoti Huang, Joshi Alumkal, et al.
Plos One
|
May 25, 2013
Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation
Lina Gao, Jacob Schwartzman, Angela Gibbs, et al.
Scientific Reports
|
December 11, 2020
Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease
Rebecca Smith, Moqing Liu, Tiera Liby, et al.
Page
of 2